REGN-5713-5714-5715
- Generic Name
- REGN-5713-5714-5715
Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Birch Pollen AllergyHealthy Volunteers
- Interventions
- Drug: Matching placebo
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 96
- Registration Number
- NCT03969849
- Locations
- 🇧🇪
Regeneron Study Site, Leuven, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath